---
figid: PMC6113426__CAS-109-2375-g003
figlink: /pmc/articles/PMC6113426/figure/cas13658-fig-0003/
number: F3
caption: Summary of apolipoprotein B mRNA editing enzyme catalytic polypeptide‐like
  (APOBEC)3B transcriptional regulations in cancer cells. APOBEC3B is the main source
  of mutagenesis in multiple types of cancer. High expression of APOBEC3B and elevated
  activity have been reported in HER2+ breast cancer, human papillomavirus (HPV)+
  cervical cancer, and head and neck squamous carcinoma. Nuclear factor kappa B (NF‐κB)
  pathway activation, DNA replication stress and HPV E6/7 oncoproteins and mutant
  p53 are able to turn on APOBEC3B expression. In contrast, WT p53 activation suppresses
  APOBEC3B expression through p21‐mediated transcriptional suppressive complexes occupancy
  of promoter region of APOBEC3B.,  AID, activation‐induced deaminase; IFN, interferon;
  TNF, tumor necrosis factor
pmcid: PMC6113426
papertitle: Apolipoprotein B mRNA editing enzyme catalytic polypeptide‐like family
  genes activation and regulation during tumorigenesis.
reftext: Jianlong Gao, et al. Cancer Sci. 2018 Aug;109(8):2375-2382.
pmc_ranked_result_index: '112505'
pathway_score: 0.8995024
filename: CAS-109-2375-g003.jpg
figtitle: Summary of apolipoprotein B mRNA editing enzyme catalytic polypeptide‐like
  (APOBEC)3B transcriptional regulations in cancer cells
year: '2018'
organisms:
- Homo sapiens
ndex: 6b460cac-deae-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6113426__CAS-109-2375-g003.html
  '@type': Dataset
  description: Summary of apolipoprotein B mRNA editing enzyme catalytic polypeptide‐like
    (APOBEC)3B transcriptional regulations in cancer cells. APOBEC3B is the main source
    of mutagenesis in multiple types of cancer. High expression of APOBEC3B and elevated
    activity have been reported in HER2+ breast cancer, human papillomavirus (HPV)+
    cervical cancer, and head and neck squamous carcinoma. Nuclear factor kappa B
    (NF‐κB) pathway activation, DNA replication stress and HPV E6/7 oncoproteins and
    mutant p53 are able to turn on APOBEC3B expression. In contrast, WT p53 activation
    suppresses APOBEC3B expression through p21‐mediated transcriptional suppressive
    complexes occupancy of promoter region of APOBEC3B.,  AID, activation‐induced
    deaminase; IFN, interferon; TNF, tumor necrosis factor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATM
  - MAPK9
  - CHEK1
  - ATR
  - MAPK14
  - MAPK10
  - CHEK2
  - MAPK11
  - MAPK12
  - MAPK1
  - MAPK13
  - ERBB2
  - IFNA1
  - RELB
  - MAPK3
  - MAPK8
  - TNF
  - NFKB1
  - LIN9
  - E2F4
  - MUT
  - TP53
  - Doxorubicin
  - Cytotoxic
  - AID
genes:
- word: ATM/ATR
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Chk1/Chk2
  symbol: CHK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK1
  entrez: '1111'
- word: ATM/ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Chk1/Chk2
  symbol: CHK2
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK2
  entrez: '11200'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: IFN)
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: RELB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: TNF,
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: LIN9
  symbol: LIN9
  source: hgnc_symbol
  hgnc_symbol: LIN9
  entrez: '286826'
- word: E2F4
  symbol: E2F4
  source: hgnc_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
chemicals:
- word: Doxorubicin
  source: MESH
  identifier: D004317
diseases:
- word: Cytotoxic
  source: MESH
  identifier: D064420
- word: AID
  source: ''
  identifier: ''
figid_alias: PMC6113426__F3
redirect_from: /figures/PMC6113426__F3
figtype: Figure
---
